
Marshall Wace’s Oramed Pharmaceuticals ORMP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-22,527
| Closed | -$55K | – | 2697 |
|
2024
Q3 | $55K | Buy |
+22,527
| New | +$55K | ﹤0.01% | 2228 |
|
2023
Q2 | – | Sell |
-10,553
| Closed | -$23K | – | 2367 |
|
2023
Q1 | $23K | Sell |
10,553
-26,846
| -72% | -$58.5K | ﹤0.01% | 2061 |
|
2022
Q4 | $450K | Buy |
37,399
+8,990
| +32% | +$108K | ﹤0.01% | 1847 |
|
2022
Q3 | $185K | Buy |
28,409
+8,900
| +46% | +$58K | ﹤0.01% | 2356 |
|
2022
Q2 | $90K | Buy |
+19,509
| New | +$90K | ﹤0.01% | 2563 |
|
2021
Q2 | – | Sell |
-11,563
| Closed | -$117K | – | 2417 |
|
2021
Q1 | $117K | Sell |
11,563
-25,069
| -68% | -$254K | ﹤0.01% | 2007 |
|
2020
Q4 | $155K | Sell |
36,632
-22,016
| -38% | -$93.2K | ﹤0.01% | 1631 |
|
2020
Q3 | $153K | Buy |
58,648
+10,388
| +22% | +$27.1K | ﹤0.01% | 1451 |
|
2020
Q2 | $170K | Sell |
48,260
-29,101
| -38% | -$103K | ﹤0.01% | 1402 |
|
2020
Q1 | $235K | Sell |
77,361
-36,345
| -32% | -$110K | ﹤0.01% | 1141 |
|
2019
Q4 | $586K | Buy |
+113,706
| New | +$586K | ﹤0.01% | 1075 |
|